Compton Capital Management Has Lowered Its Stake in Jp Morgan Chase & Co (JPM) by $763,135; Teva Pharmaceutical (TEVA) Shareholder Northern Cross Has Increased Its Position

February 23, 2018 - By Adrian Erickson

Northern Cross Llc increased its stake in Teva Pharmaceutical (TEVA) by 27.92% based on its latest 2017Q3 regulatory filing with the SEC. Northern Cross Llc bought 4.97M shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 22.76 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $400.65 million, up from 17.80 million at the end of the previous reported quarter. Northern Cross Llc who had been investing in Teva Pharmaceutical for a number of months, seems to be bullish on the $20.32 billion market cap company. The stock increased 0.93% or $0.19 during the last trading session, reaching $19.99. About 5.61 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 23, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Compton Capital Management Inc decreased its stake in Jp Morgan Chase & Co (JPM) by 9.14% based on its latest 2017Q3 regulatory filing with the SEC. Compton Capital Management Inc sold 8,033 shares as the company’s stock declined 6.04% while stock markets rallied. The institutional investor held 79,840 shares of the major banks company at the end of 2017Q3, valued at $7.63M, down from 87,873 at the end of the previous reported quarter. Compton Capital Management Inc who had been investing in Jp Morgan Chase & Co for a number of months, seems to be less bullish one the $400.91B market cap company. The stock increased 1.81% or $2.08 during the last trading session, reaching $117.06. About 8.62M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since February 23, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Deutsche Bank given on Tuesday, July 28. Credit Suisse downgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, August 4 to “Neutral” rating. The company was maintained on Wednesday, January 4 by Maxim Group. Morgan Stanley upgraded it to “Hold” rating and $18.0 target in Friday, December 15 report. The stock has “Hold” rating by Piper Jaffray on Thursday, August 3. On Wednesday, August 2 the stock rating was maintained by Mizuho with “Hold”. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Outperform” rating by Credit Suisse on Monday, February 12. The firm earned “Neutral” rating on Friday, July 15 by Goldman Sachs. Cantor Fitzgerald maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Thursday, June 22 with “Hold” rating. The firm has “Neutral” rating given on Friday, February 10 by Mizuho.

Northern Cross Llc, which manages about $51.96B and $7.77B US Long portfolio, decreased its stake in Alibaba Group Holding (NYSE:BABA) by 428,830 shares to 6.48M shares, valued at $1.12B in 2017Q3, according to the filing. It also reduced its holding in Las Vegas Sands Corp (NYSE:LVS) by 1.59M shares in the quarter, leaving it with 35.55M shares, and cut its stake in Grupo Televisa Sa (NYSE:TV).

Since October 25, 2017, it had 1 insider buy, and 9 insider sales for $22.34 million activity. $1.84M worth of JPMorgan Chase & Co. (NYSE:JPM) shares were sold by BACON ASHLEY. $7.31M worth of JPMorgan Chase & Co. (NYSE:JPM) was sold by Erdoes Mary E. on Saturday, January 13. Lake Marianne sold $1.03 million worth of stock or 9,194 shares. Giles Nicole had sold 3,783 shares worth $425,399 on Saturday, January 13. The insider Friedman Stacey sold $214,019. The insider Petno Douglas B sold 48,344 shares worth $5.43M.

Analysts await JPMorgan Chase & Co. (NYSE:JPM) to report earnings on April, 12. They expect $2.23 earnings per share, up 35.15% or $0.58 from last year’s $1.65 per share. JPM’s profit will be $7.64 billion for 13.12 P/E if the $2.23 EPS becomes a reality. After $1.76 actual earnings per share reported by JPMorgan Chase & Co. for the previous quarter, Wall Street now forecasts 26.70% EPS growth.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.28, from 1.19 in 2017Q2. It dropped, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Washington Cap Mngmt invested in 37,290 shares. Nwq Inv Mgmt Company Lc accumulated 1.38M shares or 1.61% of the stock. Inverness Counsel Lc holds 241,739 shares or 1.63% of its portfolio. Mrj reported 3.61% in JPMorgan Chase & Co. (NYSE:JPM). Retail Bank Of Hawaii accumulated 85,890 shares or 0.69% of the stock. Jarislowsky Fraser Ltd owns 1.48% invested in JPMorgan Chase & Co. (NYSE:JPM) for 2.58 million shares. Mayo Invest Advisers Ltd Liability Corporation reported 23,858 shares or 1.05% of all its holdings. Schafer Cullen has invested 1.84% in JPMorgan Chase & Co. (NYSE:JPM). Agf Invs has 2.17M shares. Eos Mngmt Limited Partnership invested in 0.76% or 26,000 shares. Monetta Incorporated reported 40,000 shares. Kemper Master Retirement Trust reported 53,000 shares or 3.03% of all its holdings. Davis R M Inc holds 0.19% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 47,112 shares. Rand Wealth Ltd has 1.25% invested in JPMorgan Chase & Co. (NYSE:JPM) for 113,368 shares. Mitsubishi Ufj Bk Corporation stated it has 7.33M shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts